References
- American Cancer Society. Colorectal cancer facts and figures 2017-2019. Atlanta, GA: American Cancer Society; 2017.
- Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83(3):217–244. doi:https://doi.org/10.1016/s0163-7258(99)00026-1
- Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 2001;61:1927–1933.
- Richter CK, Bowen KJ, Mozaffarian D, Kris-Etherton PM, Skulas-Ray AC. Total long-chain n-3 fatty acid intake and food sources in the United States compared to recommended intakes: NHANES 2003-2008. Lipids. 2017;52(11):917–927. doi:https://doi.org/10.1007/s11745-017-4297-3
- Kantor ED, Lampe JW, Peters U, Vaughan TL, White E. Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer. Nutr Cancer. 2014;66(4):716–727. doi:https://doi.org/10.1080/01635581.2013.804101
- Song M, Chan AT, Fuchs CS, Ogino S, Hu FB, Mozaffarian D, Ma J, Willett WC, Giovannucci EL, Wu K, et al. Dietary intake of fish, omega-3 and omega-6 fatty acids and risk of colorectal cancer: A prospective study in U.S. men and women. Int J Cancer. 2014;135(10):2413–2423. doi:https://doi.org/10.1002/ijc.28878
- Hull MA. Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia. Recent Results Cancer Res. 2013;191:143–156. doi:https://doi.org/10.1007/978-3-642-30331-9_8
- Aglago EK, Huybrechts I, Murphy N, Casagrande C, Nicolas G, Pischon T, Fedirko V, Severi G, Boutron-Ruault M-C, Fournier A, et al. Consumption of fish and long-chain n-3 polyunsaturated fatty acids is associated with reduced risk of colorectal cancer in a large European cohort. Clin Gastroenterol Hepatol. 2019;18(3):654–666.e6
- Rothwell PM, Price JF, Fowkes FGR, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JFF, Wilson M, Mehta Z, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379(9826):1602–1612. doi:https://doi.org/10.1016/S0140-6736(11)61720-0
- Djuric Z, Turgeon DK, Sen A, Ren J, Herman K, Ramaswamy D, Zhao L, Ruffin MT, Normolle DP, Smith WL, et al. The anti-inflammatory effect of personalized omega-3 fatty acid dosing for reducing prostaglandin E2 in the colonic mucosa is attenuated in obesity. Cancer Prev Res (Phila). 2017;10(12):729–737. doi:https://doi.org/10.1158/1940-6207.CAPR-17-0091
- Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally, occuring plant phenolic compound. Cancer Res. 1995;55:259–266.
- Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, Reddy BS. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res. 1995;55:1464–1472.
- Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis. 1993;14(8):1493–1497. doi:https://doi.org/10.1093/carcin/14.8.1493
- Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 1996;56:2556–2560.
- Cai H, Al-Fayez M, Tunstall RG, Platton S, Greaves P, Steward WP, Gescher AJ. The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice. Mol Cancer Ther. 2005;4(9):1287–1292. doi:https://doi.org/10.1158/1535-7163.MCT-05-0165
- Sale S, Tunstall RG, Ruparelia KC, Potter GA, Steward WP, Gescher AJ. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int J Cancer. 2005;115(2):194–201. doi:https://doi.org/10.1002/ijc.20884
- Short SS, Wang J, Castle SL, Fernandez GE, Smiley N, Zobel M, Pontarelli EM, Papillon SC, Grishin AV, Ford HR, et al. Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis. Lab Invest. 2013;93(12):1265–1275. doi:https://doi.org/10.1038/labinvest.2013.119
- Molendijk J, Robinson H, Djuric Z, Hill MM. Lipid mechanisms in hallmarks of cancer. Mol Omics. 2020;16(1):6–18. doi:https://doi.org/10.1039/c9mo00128j
- Del Bas JM, Caimari A, Rodriguez-Naranjo MI, Childs CE, Paras Chavez C, West AL, Miles EA, Arola L, Calder PC. Impairment of lysophospholipid metabolism in obesity: Altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial. Am J Clin Nutr. 2016;104(2):266–279. doi:https://doi.org/10.3945/ajcn.116.130872
- Straka S, Lester JL, Cole RM, Andridge RR, Puchala S, Rose AM, Clinton SK, Belury MA, Yee LD. Incorporation of eicosapentaenioic and docosahexaenoic acids into breast adipose tissue of women at high risk of breast cancer: A randomized clinical trial of dietary fish and n-3 fatty acid capsules. Mol Nutr Food Res. 2015;59(9):1780–1790. doi:https://doi.org/10.1002/mnfr.201500161
- Lands B. Historical perspectives on the impact of n-3 and n-6 nutrients on health. Prog Lipid Res. 2014;55:17–29. doi:https://doi.org/10.1016/j.plipres.2014.04.002
- Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL. Different fatty acids compete with arachidonic acid for binding to the allosteric or catalytic subunits of cyclooxygenases to regulate prostanoid synthesis. J Biol Chem. 2016;291(8):4069–4078. doi:https://doi.org/10.1074/jbc.M115.698001
- Calder PC. n-3 fatty acids, inflammation and immunity: New mechanisms to explain old actions. Proc Nutr Soc. 2013;72(3):326–336. doi:https://doi.org/10.1017/S0029665113001031
- Strandjord SE, Lands B, Hibbeln JR. Validation of an equation predicting highly unsaturated fatty acid (HUFA) compositions of human blood fractions from dietary intakes of both HUFAs and their precursors. Prostaglandins Leukot Essent Fatty Acids. 2018;136:171–176. doi:https://doi.org/10.1016/j.plefa.2017.03.005
- Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18-month controlled study. J Lipid Res. 1997;38(10):2012–2022. doi:https://doi.org/10.1016/S0022-2275(20)37132-7
- Sun Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr. 2007;86(1):74–81. doi:https://doi.org/10.1093/ajcn/86.1.74
- Roza AM, Shizgal HM. The Harris Benedict equation reevaluated: Resting energy requirements and the body cell mass. Am J Clin Nutr. 1984;40(1):168–182. doi:https://doi.org/10.1093/ajcn/40.1.168
- U.S. Department of Agriculture. Nutrient Intakes from Food and Beverages: Mean Amounts Consumed per Individual, by Gender and Age, What We Eat in America, NHANES 2009-2010. Beltsville, MD: Agricultural Research Service Ed.; 2012.
- Sen A, Zhao L, Djuric Z, Turgeon DK, Ruffin MT, Smith WL, Brenner DE, Normolle DP. An adaptive Bayesian design for personalized dosing in a cancer prevention trial. Am J Prev Med. 2020;59(4):e167–e173. doi:https://doi.org/10.1016/j.amepre.2020.04.023
- Conway JM, Ingwersen LA, Vinyard BT, Moshfegh AJ. Effectiveness of the US Department of Agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women. Am J Clin Nutr. 2003;77(5):1171–1178. doi:https://doi.org/10.1093/ajcn/77.5.1171
- Ren J, Mozurkewich EL, Sen A, Vahratian AM, Ferreri TG, Morse AN, Djuric Z. Total serum fatty acid analysis by GC-MS: Assay validation and serum sample stability. Curr Pharm Anal. 2013;9(4):331–339. doi:https://doi.org/10.2174/1573412911309040002
- Harris WS, Von Schacky C. The Omega-3 Index: A new risk factor for death from coronary heart disease. Prev Med. 2004;39(1):212–220. doi:https://doi.org/10.1016/j.ypmed.2004.02.030
- Strandjord SE, Lands B, Hibbeln JR. Validation of an equation predicting highly unsaturated fatty acid (HUFA) compositions of human blood fractions from dietary intakes of both HUFAs and their precursors. Prostaglandins Leukot Essent Fatty Acids. 2017;136:171–176.
- Watson H, Cockbain AJ, Spencer J, Race A, Volpato M, Loadman PM, Toogood GJ, Hull MA. Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases. Prostaglandins Leukot Essent Fatty Acids. 2016;115:60–66. doi:https://doi.org/10.1016/j.plefa.2016.10.003
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289–300. doi:https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
- Harris WS. The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr. 2008;87(6):1997s–2002s. doi:https://doi.org/10.1093/ajcn/87.6.1997S
- Aglago EK, Biessy C, Torres-Mejía G, Angeles-Llerenas A, Gunter MJ, Romieu I, Chajès V. Association between serum phospholipid fatty acid levels and adiposity in Mexican women. J Lipid Res. 2017;58(7):1462–1470. doi:https://doi.org/10.1194/jlr.P073643
- Yammine S, Naja F, Tamim H, Nasrallah M, Biessy C, Aglago E, Matta M, Romieu I, Gunter M, Nasreddine L, et al. Association between serum phospholipid fatty acid levels and adiposity among Lebanese adults: A cross-sectional study. Nutrients. 2018;10(10):1371. doi:https://doi.org/10.3390/nu10101371
- Peck B, Schulze A. Lipid desaturation – The next step in targeting lipogenesis in cancer? FEBS J. 2016;283(15):2767–2778. doi:https://doi.org/10.1111/febs.13681
- Lands WE, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, Schmeisser D, Davidson MH, Burns JH. Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids. Biochim Biophys Acta. 1992;1180(2):147–162. doi:https://doi.org/10.1016/0925-4439(92)90063-s
- Bibus D, Lands B. Balancing proportions of competing omega-3 and omega-6 highly unsaturated fatty acids (HUFA) in tissue lipids. Prostaglandins Leukot Essent Fatty Acids. 2015;99:19–23. doi:https://doi.org/10.1016/j.plefa.2015.04.005
- Lands B. Highly unsaturated fatty acids (HUFA) mediate and monitor food's impact on health. Prostaglandins Other Lipid Mediat. 2017;133:4–10. doi:https://doi.org/10.1016/j.prostaglandins.2017.05.002
- Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Council on the Kidney in Cardiovascular Disease, et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation. 2011;123(20):2292–2333. doi:https://doi.org/10.1161/CIR.0b013e3182160726
- Karalis DG. A review of clinical practice guidelines for the management of hypertriglyceridemia: A focus on high dose omega-3 fatty acids. Adv Ther. 2017;34(2):300–323. doi:https://doi.org/10.1007/s12325-016-0462-y
- Anagnostis P, Paschou SA, Goulis DG, Athyros VG, Karagiannis A. Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit? Maturitas. 2018;108:45–52. doi:https://doi.org/10.1016/j.maturitas.2017.11.011
- Feingold K, Grunfeld C. Triglyceride lowering drugs. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, et al. editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
- Brinton EA, Mason RP. Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA). Lipids Health Dis. 2017;16(1):23. doi:https://doi.org/10.1186/s12944-017-0415-8
- Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133(Suppl 3):925S–932S. doi:https://doi.org/10.1093/jn/133.3.925S
- Skeaff CM, Hodson L, McKenzie JE. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr. 2006;136(3):565–569. doi:https://doi.org/10.1093/jn/136.3.565
- Sanders TA, Hinds A. The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr. 1992;68(1):163–173. doi:https://doi.org/10.1079/bjn19920074
- Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Preston FE. The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis. 1985;55(3):267–281. doi:https://doi.org/10.1016/0021-9150(85)90106-6
- Bartram HP, Gostner A, Reddy BS, Rao CV, Scheppach W, Dusel G, Richter A, Richter F, Kasper H. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: Potential role of the n-3:n-6 fatty acid ratio. Eur J Cancer Prev. 1995;4(3):231–237. doi:https://doi.org/10.1097/00008469-199506000-00004
- Manni A, El-Bayoumy K, Thompson H. Docosahexaenoic acid in combination with dietary energy restriction for reducing the risk of obesity related breast cancer. Int J Mol Sci. 2017;19:28.
- Wilson MJ, Sen A, Bridges D, Turgeon DK, Brenner DE, Smith WL, Ruffin MT, Djuric Z. Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations after dietary supplementation with ω-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2018;139:14–19. doi:https://doi.org/10.1016/j.plefa.2018.11.001
- Djuric Z, Bassis CM, Plegue MA, Sen A, Turgeon DK, Herman K, Young VB, Brenner DE, Ruffin MT. Increases in colonic bacterial diversity after ω-3 fatty acid supplementation predict decreased colonic prostaglandin E2 concentrations in healthy adults. J Nutr. 2019;149(7):1170–1179. doi:https://doi.org/10.1093/jn/nxy255